Navigation Links
Sleeping Pill To Tackle Obesity Problem Also

A new sleeping tablet is being developed by scientists, which will also serve to tackle obesity and enhance the memory power. This Orexin-RA-1 tablet will also be devoid of other side effects like drowsiness during the daytime, in addition to addiction. // The hormone orexin which is directly connected to sleeping disorders and paralysis will be targeted by the new pill.

The pill has already been tested on rats, which performed better in tests the next day when compared to rats which were given conventional sleeping tablets. The REM of the new pill, which is the dream phase during the sleep was seen to be higher, serving to enhance memory.

The drug is being developed by Actelion. As the new tablet orexin is connected to eating habits, it can also be used for treating obesity. As much as 20% to 30% of the human population reportedly suffers from insomnia. The new drug may hit the market in 2012 if the tests are successful.

Source: Chemistry and Industry.
'"/>




Page: 1

Related medicine news :

1. Sleeping sickness - a silent killer
2. Help For Kids With Difficulty In Sleeping
3. Sleeping Less May be related to Weight Gain
4. Sleeping Boy Does A Rip Van Winkle
5. With New Drug To Fight Against Sleeping, Your Increment Is Not Far Away
6. Uganda Reports Failure To Contain Sleeping Sickness
7. Fluorescent markers to distinguish Trypanosoma brucei strains causing Sleeping Sickness
8. Sleeping Is No Mean Art … It Is A Privilege Denied To Many
9. Toddlers Have Respiratory Trouble When Sleeping With Their Face Up
10. Sleeping disorder risk factor for heart attacks
11. Newer Generation Sleeping Pills Lack Superior Performance
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical Institute ... The name change aligns the entire company with its existing Quality Insights ... , “We are very proud of the achievements associated with the West Virginia ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development continuity to its innovative Unified Instance Manager architecture, meeting the needs ... this new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016 aTyr Pharma, Inc. (Nasdaq: ... development of Physiocrine-based therapeutics to address severe, rare diseases, today announced ... upcoming BMO Prescriptions for Success Healthcare Conference at the InterContinental Barclay ... December 14, 2016, at 4:20 p.m. ET. About ... ...
(Date:12/9/2016)... , Dec. 9, 2016 Department of Health ... regulations for medical marijuana dispensaries under Act 16 are ... , and are now available online . ... in the plan for operation; process for dispensing medical ... well as where the dispensary facilities can be located," ...
(Date:12/8/2016)... VIEW, Calif. , Dec. 8, 2016 IRIDEX ... intends to offer newly issued shares of common stock, $0.01 ... pursuant to an underwritten public offering.  The final terms of ... the time of pricing, and there can be no assurance ... IRIDEX expects to use the net proceeds it ...
Breaking Medicine Technology: